Philips Respironics Sleep and Respiratory Care devices
We are focused on delivering the best care possible, while supporting patients, customers and clinicians throughout the remediation process.
In June 2021, after discovering a potential health risk related to the foam in certain CPAP, BiPAP and Mechanical Ventilator devices, Philips Respironics issued a voluntary Field Safety Notice (outside U.S.) / voluntary recall notification (U.S. only).
An update on our progress
Globally, we have remediated 99% of actionable* sleep therapy device registrations to date.
As the remediation of the ventilator devices continues, Philips Respironics will be communicating with Durable Medical Equipment providers (DMEs) directly throughout the process. If you are a patient or caregiver with an affected Philips Respironics ventilation device, you do not need to take any action. All ventilation remediation will be handled via your DME.
*Actionable registrations are those that contain the necessary information needed to complete the remediation and are not awaiting further information.
![Philips Respironics Sleep and Respiratory Care devices | Philips (4) Philips Respironics Sleep and Respiratory Care devices | Philips (4)](https://i0.wp.com/www.philips.ca/c-dam/b2bhc/master/landing-pages/src/update/elements/stop-sign-100.png)
Ozone and UV light cleaning products are not currently approved cleaning methods for sleep apnea devices or masks and should not be used.
Ozone Cleaner Information
Latest updates
Philips provides update on Respironics recall
October 6, 2023
Philips response to recent media articles related to Philips Respironics’ voluntary recall notification/field safety notice
September 27, 2023
All news and updates